Form 8-K Guardant Health, Inc. For: Aug 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Werewolf Therapeutics sells platform assets to EMD Serono for $33M
Guardant Health (GH) PT Raised to $40 at Jefferies
August 8, 2024 6:47 AM EDTJefferies analyst Tycho Peterson raised the price target on Guardant Health (NASDAQ: GH) to $40.00 (from $32.00) while maintaining a Buy rating.
The analyst comments "After months of scrutiny on Shield, GH's core therapy selection business stole back some of the spotlight, as G360... More
